priorauth_notes
TL2 Regular · Denver, CO, US
Insurance denials and how to read them. The denial letter usually tells you exactly what to submit next.
Joined 21 August 2025 · last posted 5h
69 posts, newest first. Showing up to 150.
-
Chain of custody for a sample you posted yourself Replied, post #3 · Sourcing › Independent verification · 28 Jul 2026 · 0 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Insomnia at a dose step: reported experiences — the long version Replied, post #44 · Wellbeing › Sleep · 9 Jul 2026 · 18 likes Confirming post #43 from a second method, which matters more than confirming it from a second person. Where sleep worsened at the same time as an escalation and…
-
Coming back to: Payment method and the leverage it gives you, ranked Replied, post #16 · Sourcing › Payments · 7 Jul 2026 · 32 likes On Payment method, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Blinding yourself: practical methods and their limits — the long version Replied, post #7 · Research Methods › N-of-1 designs · 28 Jun 2026 · 7 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
Shakes versus food: a pragmatic assessment Replied, post #19 · Nutrition & Training › Protein & intake · 25 Jun 2026 · 0 likes Temperature and texture change what is tolerable for a lot of people during the first weeks, and that is worth experimenting with before concluding nothing works. I…
-
Asking a follow-up: new topic or new reply? Replied, post #24 · Start Here › How to Ask · 25 Jun 2026 · 9 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
-
Forced degradation studies: designing one that is informative Replied, post #75 · Analytics › Method validation · 12 Jun 2026 · 18 likes Where I part company with post #72, and it is a narrow parting. Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to…
-
Micronutrient adequacy at low total intake Replied, post #71 · Nutrition & Training › Protein & intake · 12 Jun 2026 · 0 likes Protein supplements: whey, casein, and plant-based protein powders can help hit targets when whole-food intake is limited by appetite. Protein quality (all essential…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #21 · Pharmacology › Pharmacokinetics · 9 Jun 2026 · 28 likes A missed weekly dose perturbs a slowly moving average rather than creating a trough. That is the pharmacokinetic reason the labelling does not recommend doubling. The…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #95 · Practice › Storage & stability · 8 Jun 2026 · 2 likes Temperature excursions in transit are common and are not all equal. A few hours warm is a different event from three days warm, and neither is visible in the vial on…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #65 · Sourcing › Red flags · 5 Jun 2026 · 0 likes Post #62 and I disagree about the size of the effect, not about the direction. An unexplained discrepancy that the supplier declined to address is a legitimate thing to…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #68 · Start Here › Welcome · 3 Jun 2026 · 2 likes Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves your post — they are just routing it to the right…
-
Batch numbers that do not match the vial label — what changed since Replied, post #25 · Sourcing › Red flags · 30 May 2026 · 19 likes Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth…
-
Pancreatitis history and the risk calculus Replied, post #14 · Safety › Contraindications · 29 May 2026 · 23 likes Reading back through the pancreatitis history threads from last year, the same three questions come up every time and only one of them has ever been answered properly.…
-
Reading a trial's population section before its results Replied, post #58 · Evidence › Trials · 27 May 2026 · 7 likes Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #68 · Evidence › Journal club · 27 May 2026 · 2 likes The strongest argument against my own position on indirect comparison, stated as well as I can state it, since nobody else has yet.
-
Second pass at: A pooled estimate that changed when one trial was added Replied, post #12 · Evidence › Meta-analyses · 24 May 2026 · 21 likes That is clearer than the version I had in my head. Thank you.
-
Second pass at: The storage lookup and where its data comes from Replied, post #21 · Data & Tools › Calculators · 24 May 2026 · 20 likes Whatever the answer on storage lookup turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the correction.
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #30 · Practice › Administration · 20 May 2026 · 13 likes Post #27 describes the usual case. This is about the unusual one. I keep a log for Pinch specifically because my memory of it turned out to be systematically wrong in…
-
Private prescribing in the UK: what is actually involved Replied, post #11 · Regional › UK & Ireland · 8 May 2026 · 0 likes Where I part company with post #7, and it is a narrow parting. Counterpoint on private prescribing, offered without confidence: the same observation is consistent with…
-
Coming back to: Swirling versus inverting versus leaving it alone Replied, post #11 · Practice › Reconstitution · 30 Apr 2026 · 2 likes Fair, and the limits you put on it are the part I will remember.
-
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #3 · Practice › Storage & stability · 22 Apr 2026 · 14 likes Bookmarking this. I will come back when I have something worth adding.
-
[2026 update] Currency conversion and the cost you did not see Replied, post #15 · Sourcing › Payments · 14 Apr 2026 · 27 likes A definition problem is doing most of the work in this Currency conversion discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what…
-
List price versus negotiated price versus what you pay Replied, post #65 · Access › Pricing · 13 Apr 2026 · 4 likes Post #64 is the version of this I will quote in future. One addition. List prices versus negotiated prices: the price a pharmaceutical company publishes and the price…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #25 · Evidence › Journal club · 27 Mar 2026 · 23 likes I would rather this thread reach "we do not know" about orforglipron phase 2 than reach a confident answer that nobody can support when asked.
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #37 · Compounds › Cagrilintide & amylin analogues · 2 Mar 2026 · 3 likes Amylin analogues affect gastric emptying as well, so the mechanism overlaps the incretins in at least one place. That overlap is part of why the combination's…
-
Revisiting: Maintainer handover: how it works Replied, post #12 · Meta › Wiki maintenance · 23 Feb 2026 · 1 like On post #8 — agreed on the reasoning, with one qualification. Volunteering for the review on this one. I use it monthly, I have a list of three things that have aged…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #79 · Clinical › Special populations · 19 Jan 2026 · 0 likes Confirming post #77 from a second method, which matters more than confirming it from a second person. Extrapolating a point estimate to somebody well outside the…
-
The headache that turns out to be dehydration Replied, post #120 · Nutrition & Training › Hydration & electrolytes · 2 Jan 2026 · 18 likes Whatever the answer on headache turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the correction.
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #17 · Practice › Reconstitution · 31 Dec 2025 · 3 likes Worked example, since the arithmetic is the whole question. Five milligrams into one millilitre is 5 mg/mL. A 0.25 mg dose is 0.05 mL, which is five units on a U-100…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #51 · Sourcing › Vendor reports · 29 Dec 2025 · 26 likes That is a fair summary of where the discussion has got to.
-
Citation sweep results: how many references did not say what was claimed Replied, post #16 · Meta › Wiki maintenance · 11 Dec 2025 · 8 likes That matches how I use it. The general statement is what you check afterwards, not what you arrive for.
-
DXA precision and the least significant change for lean mass Replied, post #61 · Outcomes › Body composition · 11 Dec 2025 · 21 likes Confirming post #58 from a second method, which matters more than confirming it from a second person. Photographs under fixed lighting and posture are a genuine record…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #86 · Compounds › Oral incretins · 11 Dec 2025 · 0 likes PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and durations. Reading them requires attention to which trial is which because…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #75 · Compounds › Other compounds · 25 Nov 2025 · 0 likes Research use only, not approved for human use, and in this subcategory the compounds vary enormously in how much is known about them. It is worth establishing which end…
-
A genuinely late dose: what the labelling says and what people do — what changed since Replied, post #6 · Practice › Administration · 24 Nov 2025 · 0 likes Needle length matters less than angle for subcutaneous delivery in most people. A short needle at ninety degrees and a longer one at forty-five put the material in…
-
Lurking for two months before posting: was that the right call? Replied, post #71 · Start Here › Welcome · 21 Nov 2025 · 0 likes Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer that actually worked. It is not a competition and it…
-
Pen dose counters: what a click does and does not guarantee Started this topic · Devices › Pens & autoinjectors · 11 Nov 2025 · 32 likes On the subject in the title: Pen dose counters: what a click does and does not guarantee Working notes rather than a conclusion. Pen dose counters — I have the…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #6 · Sourcing › Independent verification · 2 Nov 2025 · 3 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Payment mechanics and the recovery options that do not exist Replied, post #71 · Sourcing › Payments · 22 Oct 2025 · 0 likes Fraud and scams: if a supplier demands payment upfront with no recourse if delivery fails, you are taking a risk. Reputation and history of other buyers matter. That…
-
Substitution between formats during a shortage Replied, post #73 · Access › Shortages · 11 Oct 2025 · 7 likes I had written a reply contradicting post #69 and deleted it. Here is what survived. Regional differences during a shortage are large, and a supply position in one…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #62 · Compounds › Cagrilintide & amylin analogues · 4 Oct 2025 · 7 likes Post #59 is the version of this I will quote in future. One addition. Research-use-only cagrilintide is not approved for human use and the published evidence base is a…
-
Coming back to: Where the integrator drew the baseline, and how much it moved the number Replied, post #19 · Analytics › HPLC & UHPLC · 3 Oct 2025 · 6 likes Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity…
-
Titles that describe the question, not the situation — what changed since Replied, post #34 · Start Here › How to Ask · 22 Sep 2025 · 3 likes Post #31 is right about the mechanism and I think understates the practical bit. Chromatogram questions: describe the method first. Column type, gradient, wavelength,…
-
Comparing my trajectory with the trial curves, carefully Replied, post #35 · Outcomes › Progress reports · 12 Aug 2025 · 0 likes Rate of change matters more than the absolute number for most of the questions people ask about their own series. It is the sort of thing that seems obvious in…
-
How to research a compound with no human data without deceiving yourself Replied, post #58 · Compounds › Other compounds · 2 Aug 2025 · 3 likes Post #56 answers the question as asked. The question underneath it is different. Distinguishing marketed research compounds from true chemical synthesis: some online…
-
A ten-fold dose error caught before injection — one year on Replied, post #25 · Devices › Syringes & needles · 1 Aug 2025 · 2 likes Barrel size determines resolution and nothing else. A 0.3 mL barrel and a 1 mL barrel deliver the same volume equally well; the smaller one lets you see what you are…
-
When a preprint is the best available evidence and we say so Replied, post #2 · Evidence › Preprints · 26 Jul 2025 · 3 likes The opening post put the caveat in the right place and I want to underline it. Screening on a preprint server is minimal and is not review. It filters obvious problems…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #70 · Compounds › Semaglutide · 15 Jul 2025 · 24 likes Semaglutide's structure is a modified backbone with a C18 diacid attached through a spacer. The acylation is the reason for the long half-life and it is also the reason…
-
Triple agonism: additive, synergistic, or neither? Replied, post #66 · Compounds › Retatrutide · 10 Jul 2025 · 31 likes Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is mechanistically plausible for benefit in metabolic liver disease. Whether that…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #77 · Compounds › Cagrilintide & amylin analogues · 12 Jun 2025 · 7 likes Adding the measurement that post #76 says would settle it. The most useful reply I ever got about CagriSema phase 2 paper was a request to state my units. It sounds…
-
Half-life, steady state, and accumulation worked through Replied, post #50 · Pharmacology › Pharmacokinetics · 1 Jun 2025 · 30 likes That is clearer than the version I had in my head. Thank you.
-
Shakes versus food: a pragmatic assessment — the long version Replied, post #19 · Nutrition & Training › Protein & intake · 8 May 2025 · 2 likes The reason Shakes versus food keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
-
A well-designed study with a badly written abstract Replied, post #5 · Evidence › Study critique · 1 Apr 2025 · 20 likes On well-designed study, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #39 · Compounds › Semaglutide · 14 Mar 2025 · 3 likes Everything in post #38 holds. The case it does not cover is the one I have. The 2.4 mg maintenance dose in the weight-management programme and the 1.0 mg diabetes dose…
-
Holding a dose indefinitely: is there a documented downside? Replied, post #10 · Practice › Dosing & titration · 15 Feb 2025 · 0 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
-
Criticising the method without criticising the authors Replied, post #39 · Evidence › Study critique · 13 Feb 2025 · 0 likes Something worth flagging about criticising the method without criticising: the strongest-sounding claims in this thread are the ones with no source attached, which is…
-
SNAC and the mechanism of oral peptide absorption Started this topic · Compounds › Oral incretins · 12 Feb 2025 · 0 likes On the subject in the title: SNAC and the mechanism of oral peptide absorption Working notes rather than a conclusion. A comparison question rather than a question…
-
Canadian access and provincial variation Replied, post #64 · Regional › North America · 7 Feb 2025 · 0 likes Post #60 and I disagree about the size of the effect, not about the direction. Where the canadian access and provincial variation discussion usually stalls is that…
-
Protein density versus volume when you cannot eat much Replied, post #20 · Nutrition & Training › Protein & intake · 26 Jan 2025 · 17 likes Adequate protein during a substantial deficit is the part of this conversation that gets least attention and probably deserves most.
-
Body image changing more slowly than the body Replied, post #19 · Wellbeing › Mental health · 12 Dec 2024 · 0 likes Post #17 is right about the mechanism and I think understates the practical bit. The arithmetic on body image is the easy part and it is where the errors are, which is…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #49 · Evidence › Journal club · 3 Dec 2024 · 29 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold? Replied, post #7 · Compounds › Repair & healing peptides · 23 Nov 2024 · 0 likes The pentadecapeptide sequence is short and stable enough to survive conditions that would degrade a larger peptide, which is one of the few things about it that is well…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #31 · Sourcing › Regulatory · 22 Nov 2024 · 12 likes Post #30 describes the usual case. This is about the unusual one. Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #32 · Clinical › Comorbidities · 14 Oct 2024 · 0 likes Post #31 is the version of this I will quote in future. One addition. Post-authorisation safety studies are the place where under-studied populations eventually appear,…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #40 · Analytics › Method validation · 26 Sep 2024 · 9 likes Post #38 and I disagree about the size of the effect, not about the direction. A method transferred between laboratories needs a demonstration that it performs…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #40 · Practice › Administration · 19 Sep 2024 · 1 like Post #37 put the caveat in the right place and I want to underline it. Bleeding at the injection site: normal and usually minimal. A little blood at the needle site…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #5 · Compounds › Semaglutide · 12 Aug 2024 · 14 likes Answering the question post #3 raises rather than the one it answers. On formulation: the licensed product is buffered and includes a preservative in the multi-dose…
-
How this community labels and discusses unrefereed work Replied, post #54 · Evidence › Preprints · 2 Jul 2024 · 0 likes The useful distinction on community labels is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has error…